Stanton Glantz

Stanton Glantz, PhD, conducts research on a wide range of issues, ranging from the effects of secondhand smoke on the heart, to the reductions in heart attacks observed when smoke-free policies are enacted, to how the tobacco industry fights tobacco control programs, and most recently, the effects of e-cigarettes and health policy issues surrounding marijuana legalization. His work has shown that, in terms of heart disease, the effects of secondhand smoke on blood and blood vessels are nearly as large as smoking itself. His work in this area was identified as one of the top research advances for 2005 by the American Heart Association. Glantz is principal investigator for a $20 million, five-year Tobacco Center of Regulatory Science, part of a first-of-its-kind tobacco science regulatory program by the U.S. Food and Drug Administration and the National Institutes of Health. He is author or coauthor of more than 350 papers related to secondhand smoke and tobacco control, as well as many papers on cardiovascular function and biostatistics. He has written several books, including the widely used Primer of Biostatistics and Primer of Applied Regression and Analysis of Variance. His writings include the first major review identifying involuntary smoking as a cause of heart disease and the landmark 1995 issue of JAMA on the Brown and Williamson documents, which showed that the tobacco industry knew many decades ago that nicotine was addictive and that smoking caused cancer. This publication was followed byThe Cigarette Papers, a book that has played a key role in ongoing litigation surrounding the tobacco industry. He is a member of the National Academy of Medicine.